Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferon

This publication has 24 references indexed in Scilit:

• Anti-human immunodeficiency virus type 1 activities and pharmacokinetics of novel 6-substituted acyclouridine derivatives
  Antimicrobial Agents and Chemotherapy, 1990
• A Pilot Study of Low-Dose Zidovudine in Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1990
• Targets and strategies for the antiviral chemotherapy of AIDS
  Trends in Pharmacological Sciences, 1990
• Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative
  Biochemical and Biophysical Research Communications, 1989
• New acquisitions in the development of anti-HIV agents
  Antiviral Research, 1989
• CLINICAL AND VIROLOGICAL EFFECTS OF HIGH-DOSE RECOMBINANT INTERFERON-α IN DISSEMINATED AIDS-RELATED KAPOSI'S SARCOMA
  The Lancet, 1988
• New selective antiviral agents active against the AIDS virus
  Trends in Pharmacological Sciences, 1987
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro
  Antimicrobial Agents and Chemotherapy, 1984
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
  Advances in Enzyme Regulation, 1984